![Markus Aebi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Markus Aebi
Corporate Officer/Principal bei
Institute of Microbiology
Profil
Dr. Markus Aebi is Chief Scientific Officer at Malcisbo AG and a Professor at Institute of Microbiology.
Dr. Aebi was previously employed as a Principal by Swiss National Science Foundation.
He received his undergraduate degree from the California Institute of Technology and a doctorate degree from the University of Zurich.
Aktive Positionen von Markus Aebi
| Unternehmen | Position | Beginn |
|---|---|---|
Institute of Microbiology
 Institute of Microbiology Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 22.09.2011 |
Ehemalige bekannte Positionen von Markus Aebi
| Unternehmen | Position | Ende |
|---|---|---|
Swiss National Science Foundation
 Swiss National Science Foundation Founded in 1952, the Swiss National Science Foundation (SNSF) is Switzerland’s primary organization dedicated to funding and promoting scientific research across all disciplines at universities and research institutions. The non-profit company is based in Bern, Switzerland. Operating as a private law foundation with a public mandate, SNSF invests substantial federal funds in basic and use-inspired research, supporting new projects and fellowships annually. Its governance includes a foundation council, delegates assembly, research council, and administrative offices, which oversee strategic direction, policy setting, and fair evaluation of funding applications. The research council manages the assessment of thousands of proposals each year, emphasizing transparency, equality, diversity, and international collaboration. SNSF offers diverse funding schemes, supports researchers throughout project lifecycles, and mandates open access publication of all funded research outputs. It promotes responsible research practices, supports early-career researchers, and fosters public engagement through various initiatives and communication channels. | Corporate Officer/Principal | 01.01.1994 |
Malcisbo AG
 Malcisbo AG Pharmaceuticals: MajorHealth Technology Develops novel carbohydrate-based vaccines for human and animal health | Gründer | - |
Ausbildung von Markus Aebi
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
1
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Zurich
 University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institute of Microbiology
Institute of Microbiology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swiss National Science Foundation
Swiss National Science Foundation Founded in 1952, the Swiss National Science Foundation (SNSF) is Switzerland’s primary organization dedicated to funding and promoting scientific research across all disciplines at universities and research institutions. The non-profit company is based in Bern, Switzerland. Operating as a private law foundation with a public mandate, SNSF invests substantial federal funds in basic and use-inspired research, supporting new projects and fellowships annually. Its governance includes a foundation council, delegates assembly, research council, and administrative offices, which oversee strategic direction, policy setting, and fair evaluation of funding applications. The research council manages the assessment of thousands of proposals each year, emphasizing transparency, equality, diversity, and international collaboration. SNSF offers diverse funding schemes, supports researchers throughout project lifecycles, and mandates open access publication of all funded research outputs. It promotes responsible research practices, supports early-career researchers, and fosters public engagement through various initiatives and communication channels. | |
Malcisbo AG
Malcisbo AG Pharmaceuticals: MajorHealth Technology Develops novel carbohydrate-based vaccines for human and animal health | Health Technology |
